For those curious about intrinsic nanovesicle-based therapeutics, Gi-Hoon Nam, CSO (Chief Scientific Officer) of SHIFTBIO INC. has elaborated concisely through an interview.

You can reach out for the full article through the link below:
https://lnkd.in/giyEFrdH
For those curious about intrinsic nanovesicle-based therapeutics, Gi-Hoon Nam, CSO (Chief Scientific Officer) of SHIFTBIO INC. has elaborated concisely through an interview.
You can reach out for the full article through the link below:
https://lnkd.in/giyEFrdH